{"ticker": "DIVISLAB.NS", "cached_at": "2026-02-20T17:34:02.284587", "signals": {"ticker": "DIVISLAB.NS", "current_price": 6291.0, "timestamp": "2026-02-20T17:34:02.283996", "overall_signal": {"signal": "NEUTRAL", "score": 54.96, "color": "gray", "confidence": "Medium", "strength": "Weak"}, "technical_analysis": {"score": 57.5, "signals": [{"name": "RSI", "score": 50, "weight": 20}, {"name": "MACD", "score": 85.0, "weight": 20}, {"name": "Bollinger Bands", "score": 0, "weight": 15}, {"name": "Moving Averages", "score": 50, "weight": 15}, {"name": "Volume", "score": 50, "weight": 10}, {"name": "Momentum", "score": 75, "weight": 20}]}, "fundamental_analysis": {"score": 54.69, "signals": [{"name": "P/E Ratio", "score": 0, "weight": 25}, {"name": "P/B Ratio", "score": 25, "weight": 15}, {"name": "Debt/Equity", "score": 85.0, "weight": 20}, {"name": "Profit Margin", "score": 85.0, "weight": 20}], "sector": "Pharma"}, "sentiment_score": 49.0, "sentiment_analysis": {"score": 49, "compound": -0.0123, "label": "Neutral", "color": "gray", "article_count": 10, "news": [{"title": "DIVISLAB Outlook for the Week (February 16, 2026 \u2013 February 20, 2026) - Equitypandit", "link": "https://news.google.com/rss/articles/CBMia0FVX3lxTFB1ZmszR2lvV2t2S2dES3Z6Uy1PenR6SkRHUmp2QmRiS0U2ZHJWWERCQ0hKRTNKV2hiMUhGQzAwTFp6dVZXbE5JT0UzSy1BdEhwanpYd0FEd3ZTRy1vZi1va1ZOUkU1UnI5YU04?oc=5", "publisher": "Equitypandit", "providerPublishTime": 1770949800, "sentiment": "Neutral", "sentiment_score": 0.0}, {"title": "Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st", "link": "https://news.google.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?oc=5", "publisher": "simplywall.st", "providerPublishTime": 1768876200, "sentiment": "Slightly Bearish", "sentiment_score": -0.1531}, {"title": "Stocks to BUY: Top 6 Brokerage picks with high returns backed by strong fundamentals; Tata Power and ITC in the list - Zee Business", "link": "https://news.google.com/rss/articles/CBMiigJBVV95cUxNUXFOUDdoRTVUeGRMc0VXVF9HRWozVkJYdkVBbjF5UWNBWndUREF6aThaTk16Q295NlF0NDZLdDR2ZGtXWTVjZDFIUDlQdTJiTDRfOEhvRUdWTnB5ODdrWHB1M1k5UVRKRVJDY2RzbWdxQXJXRU1QVzJBeVROcUZrVFNyb0hwOGdleVV3bGhaeFotRDJLT2tQdU9tLTI3Q1RWeTJmRGZJeHNSU1FvME5IMWJJZHY0UnU4Y3kwcGtwYU1Fa2s2V1hNUlRqQkR5Q1VTZjRDOVdBQXRtRkNDOEU4MzdlVG4tTURRMFQ4cDE3VUVwcXNDYzUteS0zMlVBZlRBTVVSdFdwa1BGQQ?oc=5", "publisher": "Zee Business", "providerPublishTime": 1766025000, "sentiment": "Very Bullish", "sentiment_score": 0.6369}, {"title": "Divis Laboratories Calls Surge with 9,031 Contracts Traded at Rs 6000 Strike Price - Markets Mojo", "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQVEhPbm1Dd2VkQUJXQ0hGRVBPaFBiS3VkaEZYU3JkV3VubVdEWkprN1VmcktBZzlNOUhKaVJKY1hqSks3VWZTN1JYX0JHdUlBTWV6UUhiS2pHNWN2c1htOG5JVzM2OHZUVDhTYXNqWHNuZnlZSnhzaWR6Q1B1eDVneU1HaHNDbkRoc2pwaG9ZTDJEN1g4bk95OFgtc1lnaFI2Zk9xWEJpbnRxeFVMSnJCMUVPbENDZjFfX195UXlnamgyekpYSldlREJEdE9wbFdLajJmd3Fn?oc=5", "publisher": "Markets Mojo", "providerPublishTime": 1759805827, "sentiment": "Slightly Bearish", "sentiment_score": -0.128}, {"title": "Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB) - simplywall.st", "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxNUWhfdHFISnhha0MwN3NUZC1RSmlRdkVpYVljOThjQ2NpZjI4MlZPTWQ5TUFySGdPamtLNGtZazZ3V1lyd2kzczJTb1dKOFFFbnZPaURtZmpOcy1wMVRrQzVPZjQ5VS1xUDlUTzNQaEJtV2tmc19aRWJKWGlDSEcxVktpVFU3MVIyckEwbTkwc3hsRTVXZWV4ekkxX25IemdNcFpsSGstbkQ5MXNmR2ZFZndfLWtUb2pSVXZpQUQ1cEFkSWtTclQwdHBXMjQ5TERnLTNQY3FsS1hvcUxLNGF1VDZlSFhXbVBET1NMWHFvWmR6QQ?oc=5", "publisher": "simplywall.st", "providerPublishTime": 1767061800, "sentiment": "Bearish", "sentiment_score": -0.2263}, {"title": "Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard", "link": "https://news.google.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?oc=5", "publisher": "Business Standard", "providerPublishTime": 1754443800, "sentiment": "Neutral", "sentiment_score": 0.0}, {"title": "Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains", "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPS2I3eHhROHRWQmdzdFUya3JRNTRHZTZCY05QbVhWSHRxeFdVUnNCb1FDaExnMmt1TE54UmJkSUlyWk1KaGt5X3Y4SmY0VDl4RUVIeEFJNnlqeFpjaWdNdFF5NFhaRjVsaE85cWVqV012WU9xVDdDbjRNS2RrZC10Nmx6aGxXbjhRaHIyaS1xSzN4ZVlKNmxqdUhsTUJaM1dSaHVjYlNwNWctY1c3WDk3QVB1cw?oc=5", "publisher": "Trade Brains", "providerPublishTime": 1760059800, "sentiment": "Neutral", "sentiment_score": 0.0}, {"title": "Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint", "link": "https://news.google.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?oc=5", "publisher": "Mint", "providerPublishTime": 1746581400, "sentiment": "Neutral", "sentiment_score": -0.0258}, {"title": "Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st", "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxQUFdFSjQ0ZnFPcFNlaXViNW1zVF9wbEN5cURSUE5qblJ2RTVlaHQxUnA2QUl6Z2k0MXR4b0N3TC1zV1JUZ0NiM3oxa25RSHBhell5U1JseS1PMlJOQ3UwQzd0d0ZVMnpILWp5b3hpZWNnV1pYSGFxMm8tc1cwdU1QUHBfS2RXVV9vcXk1Q3VLT3h4VE9yV1dGYS1oMVktejRSbERzLUcxMTQ1WFF1YWdTeHJxU0dpSi1NTy1qdnRseU5PdzRhRVBpWE41dVRMV3JDOUpKOUNNM19PZXlOUWF0WjVET3ktaGlxVDltQ1B2TTVnQQ?oc=5", "publisher": "simplywall.st", "providerPublishTime": 1762828200, "sentiment": "Bearish", "sentiment_score": -0.2263}, {"title": "Divis Lab inks long-term global pharma deal - Business Standard", "link": "https://news.google.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?oc=5", "publisher": "Business Standard", "providerPublishTime": 1748050200, "sentiment": "Neutral", "sentiment_score": 0.0}], "note": "Analyzed 10 recent articles"}, "timeframe_signals": {"intraday": {"timeframe": "1-3 Days", "signal": "BUY", "score": 60, "description": "Short-term scalping and day trading"}, "swing": {"timeframe": "1-4 Weeks", "signal": "BUY", "score": 85.0, "description": "Medium-term swing trading"}, "long_term": {"timeframe": "3-12 Months", "signal": "SELL", "score": 10, "description": "Long-term position trading"}}, "vwap_strategy": {"signal": "NEUTRAL", "score": 85, "effectiveness": "EXCELLENT (70-76% win rate)", "recommendation": "Use this strategy - Perfect for intraday trading", "vwap_data": {"vwap": 6223.053632979026, "upper_band_1": 6378.690972740216, "lower_band_1": 6067.416293217835, "upper_band_2": 6534.328312501407, "lower_band_2": 5911.778953456645, "upper_band_3": 6689.965652262597, "lower_band_3": 5756.141613695454, "position": "Above VWAP", "position_score": 60, "distance_from_vwap_percent": 1.091849291815405}, "price_action": {"patterns": ["Doji"], "signal_strength": 5, "dominant_pattern": "NEUTRAL"}, "confirmations": 1.0, "timeframe_suitability": {"intraday": "\u2705 EXCELLENT (70-76% win rate)", "day_trading": "\u26a0\ufe0f MODERATE (65-70% win rate)", "swing": "\u274c NOT RECOMMENDED - Use MACD + EMA instead", "long_term": "\u274c NOT RECOMMENDED - Use Fundamental Analysis instead"}, "strength": "Strong"}, "key_indicators": {"rsi": 53.68, "macd_histogram": 29.8099, "price_vs_sma50": "Above", "price_vs_sma200": "Below", "volume_ratio": 0.8, "adx": 31.37, "atr": 214.7857}, "confidence_level": "Low", "signal_conflicts": {"has_conflicts": true, "conflict_count": 2, "conflicts": ["\u26a0\ufe0f CONFLICT: Short-term bullish but long-term bearish - Counter-trend trade, use tight stops", "\u26a0\ufe0f CONFLICT: Swing trade bullish but long-term bearish - Short-term trade only, exit quickly"], "priority": {"has_conflicts": true, "recommendations": [{"trading_style": "Intraday/Day Trading", "priority_signal": "NEUTRAL", "priority_score": 85, "reason": "VWAP strategy has 70-76% historical win rate for intraday, prioritize it over other signals", "action": "Follow VWAP signal, ignore conflicting intraday signal"}, {"trading_style": "Swing Trading (1-4 weeks)", "priority_signal": "BUY", "priority_score": 85.0, "reason": "Swing signal uses multi-indicator confluence over 50 days", "action": "Follow swing signal for 1-4 week holds"}, {"trading_style": "Long-term Investing (3-12 months)", "priority_signal": "SELL", "priority_score": 10, "reason": "Long-term signal focuses on trend following with 200-day MA", "action": "Follow long-term signal, ignore short-term noise"}]}}, "risk_management": {"stop_loss": null, "take_profit": null, "position_size_pct": 0.0, "risk_reward_ratio": 0.0, "recommendation": "\u26d4 NO TRADE - Signal too weak/neutral"}, "trading_recommendation": {"recommendation": "\u26d4 DON'T TRADE - Too many conflicting signals (2 conflicts)", "safety_level": "UNSAFE", "confidence": "Low"}}}